Interestingly, the expression of ET-1 has been observed to be higher in many cancer cell types, specifically in ovarian carcinoma and in colorectal carcinoma, which is an incentive to investigate the underlying mechanisms of the role ET-1 plays in mediating tumour progression [12,14]. The gene discussed is EDN1; the disease is cancer.